Published in Am J Health Syst Pharm on January 01, 2005
A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment. Neuropsychopharmacology (2005) 3.78
Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant. Biol Psychiatry (2004) 1.28
Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression. Neuropsychopharmacology (2004) 1.10
Is bigger better for depression trials? J Psychiatr Res (2007) 0.92
Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study. Headache (2004) 0.88
Addition of an NK1 receptor antagonist to an SSRI did not enhance the antidepressant effects of SSRI monotherapy: results from a randomized clinical trial in patients with major depressive disorder. Hum Psychopharmacol (2014) 0.76